OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Organization: PharmatrophiX

6 Projects | 2 Researchers | $6,989,700 Invested

2024

PharmatrophiX

Anne Longo, BA

Phase 2b/3 trial of LM11A-31-BHS for Alzheimer's Disease

  • Funding Amount: $5,609,700
  • Organization Type: Biotechnology/For Profit
  • Program: Clinical
  • Target: Growth Factors/Neurotrophic Factors
  • Status: Active

2016

PharmatrophiX

Frank Longo, MD, PhD

2015 Goodes Prize for Excellence in Alzheimer's Drug Discovery: IND-Enabling Development of Small Molecule TrkB Ligands for Alzheimer's Therapeutics

  • Funding Amount: $150,000
  • Organization Type: Biotechnology/For Profit
  • Program: Drug Discovery
  • Status: Closed

2015

PharmatrophiX

Frank Longo, MD, PhD

P75 Receptor Modulation for AD: Phase 2a POM/Safety/Exploratory Endpoint Trial

  • Funding Amount: $500,000
  • Organization Type: Biotechnology/For Profit
  • Program: Clinical
  • Target: Growth Factors/Neurotrophic Factors
  • Status: Closed

2013

PharmatrophiX

Frank Longo, MD, PhD

Phase 1 Study for P75 Small Molecule Ligand

  • Funding Amount: $250,000
  • Organization Type: Biotechnology/For Profit
  • Program: Clinical
  • Target: Growth Factors/Neurotrophic Factors
  • Status: Closed

2009

PharmatrophiX

Frank Longo, MD, PhD

Inhibition of Alzheimer-related neurodegeneration by small molecule neurotrophin receptor ligands

  • Funding Amount: $180,000
  • Organization Type: Biotechnology/For Profit
  • Program: Drug Discovery
  • Target: Growth Factors/Neurotrophic Factors
  • Status: Closed

2006

PharmatrophiX

Frank Longo, MD, PhD

Inhibition of Alzheimer-related neurodegeneration by small molecule neurotrophin receptor ligands

  • Funding Amount: $300,000
  • Organization Type: Biotechnology/For Profit
  • Program: Drug Discovery
  • Target: Growth Factors/Neurotrophic Factors
  • Status: Closed